BioAtla (BCAB) IPO Opens 70% Higher

Today's IPO for BioAtla, Inc. (NASDAQ: BCAB) opened for trading at $30.55 after pricing 10,500,000 shares of common stock at a public offering price of $18.00 per share. All of the shares of common stock are being offered by BioAtla.

In addition, BioAtla has granted the underwriters a 30-day option to purchase up to an additional 1,575,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

J.P. Morgan, Jefferies and Credit Suisse are acting as joint book-running managers for the offering.

BioAtla is a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

You May Also Be Interested In

• SpaceX short sellers gain $15.5 billion as shares fall below IPO price
• Google Says It Holds $94 Billion In Spacex Shares After IPO
• Market Technology Acquisition Corp prices $200M IPO on Nasdaq